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GENERAL OVERVIEW 
 
Staphylococcus aureus is a facultatively anaerobic, Gram-positive coccus.  
S. aureus has been recognized as serious pathogen for over a century (1, 2) 
particularly in hospitals, they remain the most common cause of community- 
and health care-associated bacteremia. Of the approximately 2 million of 
patients who acquire a health care-associated infection annually in the United 
States, approximately 230.000 will have an infection associated with S. aureus 
(3,4).  
The disease spectrum of the S. aureus includes abscesses, bacteremia, central 
nervous system infections, endocarditis, osteo-myelitis, pneumonia and a host 
of syndrome caused by endotoxins, including food poisoing and toxic shock 
syndrome.   
The incidence of nosocomial infections is steadily increasing due to medical 
interventions and antibiotic resistance. Today, approximately half of all S. 
aureus strains isolated in hospitals worldwide are resistant to multiple 
antibiotics, such as methicillin, rendering disease management difficult. To date 
there are no approved prophylactic vaccines so, effective treatment and 
prevention strategies are urgently needed. 
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Although S. aureus is considered to be an extracellular, pyogenic pathogen 
recent in vitro studies have revealed that S. aureus can invade a variety of not 
professional phagocytes cells (5,6). Internalized bacteria reside in endosomal 
vacuoles or are diverted from the endosomal pathway to autophagosomes 
depending on the cell type invaded and/or the S. aureus strain (7). 
Professional phagocytes such as neutrophils, macrophages and dendritic cells 
are designed to engulf microbes and kill them. Only a few types of microbial 
pathogen can survive phagocytosis by neutrophils and macrophages and they 
do so by using several distinct mechanisms to avoid destruction in 
phagolysosomes (8). Surprisingly, S. aureus also appears to be resistant to 
bactericidial attack inside the phagocytic vacuoles of neutrophils which can 
contain viable intracellular bacteria when isolated from sites of infections. 
Recent in vivo studies confirmed the high level of resistance to killing by 
neutrophils (9). 
 
The objective of my PhD thesis is to study two aspects of the host-pathogen 
interaction of S. aureus with the host cells: firstly the recognition step and 
secondly the internal localization of the pathogen during the phagocytosis 
process. In particular the first part of this study is focused on the analysis of the 
binding between the HL-60 neutrophils receptors and S. aureus receptors 
expressed on the surface; while the second part is focused on the intracellular 
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localization of bacteria. For the first purpose CD1 mice were immunized with 
final vaccine protein formulations. The collected animal sera were tested in 
order to evaluate the functional activity of vaccine specific antibodies by 
opsonophagocytosis assay (OPKA). The data show a low level of killing of S. 
aureus cells suggesting that the pathogen is not undergoing to the phagocytic 
pathway normally activated by the infected cell. We also performed 
intracellular survival studies and obtained results showing that S. aureus 
persists inside phagocytes up to six hours followed by a burst of growth in the 
supernatant immediately after. These data suggest that the strong survival 
ability of S. aureus in the phagocytes can be the cause of the low killing level 
measured by OPKA. To gain a broader view of the internalization steps in which 
S. aureus occurs during his uptake in the host cell we decided to investigate its 
localization in HL-60 cells compartments by three different type of microscopy 
able to generate different kind of morphological information: confocal 
microcopy, scanning electron microscopy (SEM) and transmission electron 
microscopy (TEM). Interestingly we observed that staphylococcus cells have an 
intracellular localization, more specifically inside the vacuoles, during their 
entire pathogenic life, and moreover that are able to maintain the integrity of 
their membrane indicating a preservation of their wellness.  Evidence of this 
status is that many of the bacteria present in the vacuoles are not only alive 
but also even in the process of dividing inside vacuolar compartments. Finally 
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in order to generate 3D volume of whole bacteria when present inside 
neutrophilic vacuoles, we collected a series of tomographic two-dimensional 
(2D) images by using a transmission electron microscope.  We generate 5 
different tomograms and for each tomogram more than 120 images were kept, 
one for each tilt angle. After image analysis we produce a three-dimensional 
model of a specific volume of a cell containing the S. aureus in a vacuole 
compartment. The three-dimensional reconstruction reveals the presence of 
intact bacteria within neutrophil vacuoles. The S. aureus membrane appears 
completely undamaged and integral in contrast with the physiological process 
of phagosytosis through vacuoles progression. S. aureus bacteria show a 
homogenous distribution of the density in all the three dimensions (X, Y, Z). No 
preferential density distribution has been noticed and the cell turgor is 
maintained. All these evidences definitely explain the ability of the pathogen to 
survive inside the endosomal vacuoles and should be the cause of the low 
killing level.  
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1. INTRODUCTION 
1.1 Staphylococcus aureus  
Staphylococcus aureus is a spherical (coccus) Gram-positive bacterium, about 1 
micrometer in size, with thick cell wall and thin capsule. It does not form spores, 
but it can still survive outside the body, for example, on bed lining or computer 
keyboards from few days to several weeks. It is a facultative anaerobe – it 
grows in the air, but can also thrive in anaerobic conditions. It is an 
opportunistic pathogen – it may be present in the body without causing any 
harm, but in lowered immunity or injury, it may cause a disease. Staph bacteria 
have no flagella, so they are immobile. They grow in pairs, short chains or 
clusters. S. aureus bacteria are resistant to temperatures as high as 122 °F 
(50°C), to high salt concentrations (<10%), and to drying (11). Colonies are 
usually 6-8 mm in diameter, rounded and smooth, golden yellow or pale yellow 
to orange. 
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1.2 The epidemiology of Staphylococcus aureus  
 Staphylococcus aureus causes a variety of diseases, ranging from innocuous 
skin infection to more serious and life-threatening diseases. Of the 
approximately 2 million patients who acquire a health care-associated infection 
annually in the United States, approximately 230.000 will have an infection 
associated with Staphylococcus aureus 1, 2 . The disease spectrum of S. aureus 
includes abscesses, bacteremia, central nervous system infections, endocarditis, 
osteomyelitis, pneumonia, urinary tract infections, and a host of syndromes 
caused by exotoxins, including bullous impetigo and toxin shock syndrome. 
Remarkably, in addition to being the leading cause of bacteremia in the United 
States, S. aureus is the most common cause of food-borne illness and skin 
diseases 3, 4 (Figure 1).  
Figure 1: Anti-surface protein Immune Gold 
Electron microscopy of fixed S. aureus 
Newman strain: bacterium shows a size 
around 1 micrometer and typically grows in 
pairs.  
12 
 
 
 
1.3 Community acquired infections 
            
            Colonization and infection of skin and soft tissue  
S. aureus is able to colonize a sizable portion of the human population: the 
colonization gives to the pathogen the possibility to access to skin sites, which, 
when infected, can serve as a source for more serious diseases such as 
bacteremia, endocarditis or toxemias. Approximately 30% of the population is 
stably colonized with S. aureus and as many as 30% to 50% of the population 
may show transient colonization of the nares, axilla, perineum, or vagina 5-7. 
Diabetics, intravenous (i.v.) drug users, patients on dialysis, and patients with 
 
Figure 1: Schematic 
overview of the main 
associated S. aureus 
diseases: the graph has 
been made on the basis 
of disease severity and 
size of affected 
population.  S. aureus is 
the most common cause 
of health care-associated 
infections, including 
pneumonia, bacteremia 
and skin infections. 
(Broughan J. et al., 2011) 
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AIDS have higher rates of S. aureus colonization 8-12. Hospitalized patients and 
health care workers are also at higher risk of becoming colonized for extended 
period of time5. 
 
Skin Infections 
Approximately one-half of all skin infections are caused by S. aureus 13. 
Infections include carbuncles, cellulitis, folliculitis, hydradenitis suppurtiva, 
impetigo, mastitis, pyodermas, and pyomyositis. Impetigo, which involves 
release of epidermolytic toxins, can range from mild, recurrent infectioons to 
the more serious bullous impetigo, characterized by blisters that continually 
break and become infected, to the potentially life-threatening scaled skin 
syndrome 14. 
 
Bacteremia and Endocarditis  
Virtually any S. aureus infection can lead to bacteremia. S. aureus causes about 
11 to 38% of community- acquired bacteremia 15, 16. Mortality from S. aureus 
bacteremia ranges from 11 to 48%, a figure that has increased steadily from a 
number of years 17.  
Approximately 10 to 40% of community-acquired cases of S. aureus bacteremia 
progress to endocarditis 17, 18. This figure is higher in i.v. drug users often 
because they are heavily colonized with S. aureus and have frequent breaches 
14 
 
of skin barriers, and is lower in patients with nosocomial bacteremia. S. aureus 
differs from many other pathogens in that it can cause infectious endocarditis 
on a normal, native heart valve.  
 
Toxin-mediated Diseases   
Several staphylococcal diseases are mediated by toxins, including impetigo, 
food poisoning, necrotizing pneumonia, and toxic shock syndrome. 
Staphylococcal food poisoning is a result of ingesting one of several 
staphylococcal enterotoxins, the most ubiquitous of which is enterotoxin A 19-21. 
The disease mediated by toxic shock syndrome 1 (TSST-1) was first described in 
1978 and consists of fever above 39°C, hypotension, rush, usually followed by 
desquamation of the skin, and involvement of multiple organ system.  
Panton-Valentine leukocidin (PVL) is a biocomponent synergomenotropic 
staphylococcal cytotoxin that causes leukocyte destruction and tissue 
necrosis22. Although its precise role in disease is unclear, it has been associated 
with necrotic lesions involving the skin and severe necrotizing pneumonia 22.  
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1.4 Health care- associated infections   
Staphylococci are among the most common causes of health care-associated 
infections, including bacteremia, surgical site infections (SSIs), and pneumonia 
23.  Data from the National Nosocomial Infection Surveillance (NNIS) system 
from intensive care units (ICUs) for 2000 to 2004 show S. aureus to be the most 
common cause of nosocomial pneumonia and surgical site infections, and the 
third most common cause of nosocomial bloodstream infection. 
 
1.5 Antimicrobial resistance  
 
Antimicrobial resistance in the hospital setting  
Several reports suggest that the prevalence of S. aureus strains resistant to 
methicillin, oxacillin, or nafcillin is increasing in the United States and abroad 24-
28. The ability of this pathogen could be due to its intrinsic virulence, and its 
capacity to adapt to environmental conditions 14. S. aureus isolates from 
intensive care units across the country and from blood culture isolates 
worldwide are increasingly resistant to a greater number of antimicrobials 
agents 29. As rapidly as new antibiotics are introduced, S. aureus has developed 
efficient mechanism to neutralize them    (Table 1, Lowy F.D., 2003). 
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Penicillin resistance  
The mortality of patients with S. aureus bacteremia in the pre-antibiotic era 
exceeded 80% and over 70% developed metastatic infections. The introduction 
of penicillin in the early 1940s dramatically improved the prognosis of patients 
with staphylococcal infections. However, as early as 1942, penicillin-resistant 
staphylococci were recognized, first in hospitals and subsequently in the 
community. By the late 1960s, more than 80% of both community and hospital-
acquired staphylococcal isolates were resistant to penicillin.  The mechanism of 
resistance of S. aureus is mediated by blaZ, the gene that encodes β-lactamase. 
This predominantly extracellular enzyme, synthetized when staphylococci are 
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exposed to β-lactam antibiotics, hydrolyzes the β-lactam ring, rendering the β-
lactam inactive 30.  
                Methicillin resistance  
Methicillin, introduced in 1961, was the first of the semisynthetic penicillinase-
resistant penicillins. Its introduction was rapidly followed by reports of 
methicillin-resistant isolates. The first reports of a S. aureus strain that was 
resistant to methicillin were published in 1961 31. Although the specific gene 
responsible for methicillin resistance (mecA, which encodes the low-affinity 
penicillin-binding protein PBP2a (also known as PBP2') was not identified until 
over 20 years later, it was appreciated early on that the resistance mechanism 
involved was different from penicillinase-mediated resistance because drug 
inactivation did not occur. Unlike penicillinase-mediated resistance, which is 
narrow in its spectrum of activity, methicillin resistance is broad, conferring 
resistance to the entire β-lactam class of antibiotics, which include penicillins, 
cephalosporins and carbapenems. Outbreaks of infections caused by MRSA 
strains were reported in hospitals in the United States in the late 1970s, and by 
the mid-1980s these strains were endemic 32, 33 , leading to the worldwide 
pandemic of MRSA in hospitals that continues to the present time. Although 
global in its distribution and impact, MRSA was still confined mainly to 
hospitals and other institutional health care settings, such as long-term care 
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facilities. The ever-increasing burden of MRSA infections in hospitals led to the 
increased use of vancomycin, the last remaining antibiotic to which MRSA 
strains were reliably susceptible. This intensive selective pressure resulted in 
the emergence of vancomycin-intermediate S. aureus (VISA) strains, which are 
not inhibited in vitro at vancomycin concentrations below 4–8 g ml-1 34, 35, and 
vancomcyin-resistant S. aureus (VRSA) strains, which are inhibited only at 
concentrations of 16 g ml-1 or more 36, 37 (Figure 2). 
 
 
 
 
 
Figure 2: The four waves of antibiotic resistance in 
Staphylococcus aureus. Wave 1 (indicated above the 
graph) started after the introduction of penicillin into 
clinical practice. After few years, the first penicillin 
resistant strain (Phage type 80/81) appeared. Wave 2 
began almost immediately following the introduction 
of methicillin into clinical practice with the isolation of 
the first MRSA strain (an archaic clone),which 
contained staphylococcal chromosome cassette mec I 
(SCCmecI) (indicated on the graph as MRSA-I); this 
wave extended into the 1970s in the form of the 
Iberian clone. Wave 3 began in the mid to late 1970s 
with the emergence of new MRSA strains that 
contained the new SCCmec allotypes, SCCmecII and 
SCCmecIII (MRSA-II and MRSA-III), marking the 
ongoing worldwide pandemic of MRSA in hospitals 
and health care facilities. The increase in vancomycin 
use for the treatment of MRSA infections eventually 
led to the emergence of vancomycin-intermediate S. 
aureus (VISA) strains. Wave 4, which began in the mid 
to late 1990s, marks the emergence of MRSA strains 
in the community. Community-associated MRSA (CA-
MRSA) strains were susceptible to most antibiotics 
other than β-lactams, were unrelated to hospital 
strains and contained a new, smaller, more mobile 
SCCmec allotype, SCCmecIV (MRSA-IV) and various 
virulence factors, including PVL. Vancomycin-resistant 
S. aureus (VRSA) strains, ten or so of which have been 
isolated exclusively in health care settings, were first 
identified in 2002.(Chambers et al., 2009) 
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1.6 Neutrophils in innate host defense against Staphylococcus 
aureus infections  
Neutrophils development  
Neutrophils are short-lived granulocytes derived from pluripotent 
hematopoietic stem cells in the bone marrow [72]. During the early step of 
differentiation, cells develop phagocytic capacity followed by development of 
oxygen-dependent microbial activity, increase adhesiveness, cell motility, 
chemotactic response and other cell type-specific traits, proceeding through a 
well-characterized progression into mature neutrophils [73, 74]. For many 
pathogens, like Francisella, the ability to survive and proliferate within 
mammalian cells is essential for their virulence [75]. In order to replicate within 
macrophages Salmonella Enterica must withstand or surmount bacteriostatic 
and bactericidal responses by the host cell, including the delivery of hydrolytic 
enzymes from lysosomes to the phagosome [76]. During maturation the 
number of mitochondria and ribosomes decrease, while glycogen granules, the 
main source of energy, fill the cytoplasm of mature neutrophils. There are two 
major populations of granules present in mature neutrophils. Primary or 
azurophilic granules, which are first to develop during granulopoiesis, contain 
myeloperoxidase (MPO) and a variety of proteolytic enzymes (cathepsins, 
proteinase-3, and elastase), antimicrobial defensins, and 
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bactericidal/permeability-increasing protein [73,[77-79]]. These microbicidal 
granules are considered unique from lysosomes, in that they lack traditional 
lysosomal membrane markers and traffic as regulated secretory granules [122–
125]. The other major type of granules present are secondary or specific 
granules, which mature late during differentiation, and contain a number of 
functionally important membrane proteins including flavocytochrome b558, 
lactoferrin, collagenase, as well as receptors for chemotactic peptides, 
cytokines, opsonins, adhesion proteins, and extracellular matrix proteins [73]. 
Upon maturation, neutrophils are released into the bloodstream where they 
circulate for ∼10–24 h before migrating into tissue where they may function 
for an additional 1–2 days before undergoing apoptosis and being cleared by 
macrophages [80]. Normal neutrophil turnover in an average adult is on the 
order of 10-11 cells per day [75]. In addition to maintaining steady-state levels 
of circulating neutrophils, the hematopoietic system has the remarkable ability 
to drive “emergency” granulopoiesis in response to the increased demand of 
infection, expanding the pool of neutrophils in circulation when necessary [81, 
82]. 
Neutrophils recruitment  
A dynamic portion of circulating neutrophils rolls along the walls of post 
capillary venules for signs of tissue damage, inflammation or invading 
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microorganism. In response to damage or the presence of invading pathogens, 
a variety of host cells produce and secrete potent inflammatory mediators and 
neutrophil chemo-attractants like interleukin-8 (IL-8,CXCL8), GROα (CXCL1), 
granulocyte chemotactic protein 2 (GCP2, CXCL6), and leukotriene B4 (LTB4) 
which bind and engage specific surface receptors on surveying neutrophils. 
Contemporary S. aureus  surface components such as lipoteichoic acid (LTA) or 
capsular polysaccharide as well as secreted molecule such as toxic shock 
syndrome toxin (TSST)-1, staphylococcal enterotoxin A, and staphylococcal 
enterotoxin B have been shown to elicit IL-8 production by monocytes, 
epithelial cells, and endothelial cells [83-85]. Bacterial-derived products such as 
N-formyl peptides or the phenol-soluble modulins (PSMs) produced by S. 
aureus have the demonstrated ability to recruit neutrophils directly [86]. 
Corroborating evidence to date demonstrates that the more responsive state 
of the neutrophil is attributable to (a) partial assembly of the NADPH oxidase, 
(b) reorganization of the plasma membrane and redistribution of signaling 
molecules into lipid rafts, (c) modulation of intracellular signaling intermediates, 
(d) mobilization of secretory vesicles and enrichment of specific surface 
receptors (CD11b/CD18), (e) cytokine secretion, and (f) transcriptional 
regulation of several gene families. Although priming leads to observable 
phenotypic differences, it remains distinct from neutrophil activation in that it 
triggers neither release of azurophilic granules nor production of superoxide. 
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Pathogen recognition and phagocytosis  
Once at the site of infection, the real work for neutrophils begins, as they bind 
and ingest invading microorganisms by a process known as phagocytosis, a 
critical first step in removal of bacteria during infection. Neutrophils recognize 
numerous surface-bound and freely secreted bacterial products such as PGN, 
lipoproteins, LTA, lipopolysaccharide, CpG-containing DNA, and flagellin. Such 
conserved bacterial products are generally known as pathogen associated 
molecular patterns (PAMPs) and are recognized directly by pattern recognition 
receptors (PRRs) expressed on the surface of the neutrophil. Engagement of 
such receptors activates signal transduction pathways that prolong cell survival, 
facilitate adhesion and phagocytosis, induce release of cytokines and 
chemokines, elicit degranulation, and promote reactive oxygen species (ROS) 
production and release, ultimately contributing to microbicidal activity [87]. 
These molecules enhance recognition by surface receptors on neutrophils 
(opsonization via the lectin pathway of complement activation), activate other 
PRRs, facilitate efficient phagocytosis, and elicit release of cytokines and 
production of ROS [88-90]. Peptidoglycan recognition protein (PGRP) is a 
secreted host protein that binds PGN and Gram-positive bacteria [91, 92]. An 
isoform known as PGRP-short is produced by neutrophils and contributes 
directly to bactericidal activity rather than directing downstream signaling 
responses [93]. Unlike the unique phagocytic uptake induced by dectin-1, 
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phagocytosis of most microorganisms is promoted or at least markedly 
enhanced by opsonization with serum host factors, such as specific antibody, 
complement, and/or MBL (generally fungi) [94]. For this purpose, neutrophils 
express multiple antibody-Fc and serum complement receptors, including CD16 
(FcγIIIb, low affinity IgG receptor)[95], CD23 (FcεRI, IgE receptor) [96], CD32 
(FcγRIIa, low affinity IgG receptor) [97], CD64 (FcγRI, IgG receptor), CD89 (FcαR, 
IgA receptor) [98], CIqR [99], CD35 (CR1) [100, 101], CD11b/CD18 (CR3) [102, 
103], and CD11c/CD18 (CR4) [104]. Activation of complement facilitates the 
deposition of complement components C3b, iC3b, and Clq on the surface of 
invading microorganisms, and serum complement is fixed readily on the 
surface of antibody-coated microbes. Taken together, the combined action of 
PRRs, and complement and antibody receptors maximizes recognition and 
phagocytosis of invading microorganisms. 
1.7 Staphylococcus aureus and the complement system     
 
1.7.1 The complement system 
The plasma proteins of the complement system are essential in the innate 
immune response against bacteria. Complement labels bacteria with opsonins 
to support phagocytosis and generates chemo-attractants to attract 
phagocytes to the site of infection. In turn, bacterial human pathogens have 
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evolved different strategies to specifically impair the complement response. 
The innate immune system plays a critical role in our host defense against 
invading pathogens. The complement system consists of three different parts: 
(a) the complement system, (b) phagocytes, and (c) antimicrobial peptides. The 
three major functions of the complement cascade in innate immunity are 38 to 
label pathogens or immunogenic particles with C3b and iC3b to facilitate 
phagocytic uptake via complement receptors, 39 to attract phagocytes by 
producing chemoattractant C5a, and 40 to directly lyse gram-negative bacteria 
through membrane attack complex (MAC; C5b-9) formation 38. Complement is 
initiated by two specific recognition pathways, the classical and lectin pathway, 
which are amplified by the alternative pathway. All three pathways converge at 
the formation of the C3 convertases. These bimolecular surface-bound enzyme 
complexes catalyze the key reaction in complement activation: cleavage of 
complement protein C3 into C3a, a chemoattractant with bactericidal activity, 
and C3b 41. Convertase formation is pivotal in complement activation since C3b 
and its inactive derivative iC3b facilitate phagocytosis. Furthermore, the 
deposited C3b can form new convertases, thereby amplifying the opsonization 
process. Subsequently, the high concentrations of locally deposited C3b induce 
a shift in substrate specificity of the convertase to complement protein C5. The 
cleavage products of C5 are C5a, a potent chemoattractant, and C5b that 
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initiates the lytic pathway. Due to the resulting C5a gradient, neutrophils 
migrate toward the site of infection and phagocytose the invaders. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Schematic overview of the complement system. The complement cascade is 
activated by recognition of microbe-bound antibodies or microbial sugars by the C1 
complex (CP) or the MBL- and ficolin-MASP-2 complex (LP),respectively. The Alternative 
Pathway (AP) C3 convertase C3bBb is generated after binding of fB to surface-bound C3b 
and subsequent cleavage by fD. (Laarman et al., 2010) 
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1.7.2 Immune evasion by Staphyloccus aureus  
                Virulence factors of S.aureus: 
S. aureus secretes immunomodulatory protein that compromise both induced 
humoral and cell-mediated immunity. This pathogen expresses a wide array of 
secreted and cell-surface-associated virulence factors, including surface 
proteins that promote adhesion to damage tissue and to the surface of host 
cells. Moreover S. aureus expresses an array of extracellular enzymes such as 
proteases, a hyaluronidase, a lipase and a nuclease that facilitate tissue 
destruction and spreading, membrane-damaging toxins that cause cytolytic 
effects on host cells and tissue damage, and superantigens that contribute to 
the symptoms of septic shock42.   
One major class of surface-located proteins comprises those that are covalently 
anchored to cell-wall peptidoglycan by sortase, a membrane-associated 
enzymes that recognizes and cleaves the C-terminal LPXTG motif in the sorting 
signal 43, 44.  
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                Inhibition of neutrophil chemo taxis  
 
Immediately as the bacterium gains a foothold in the host and starts to grow, 
several chemoattractants are liberated which are specifically recognized by 
neutrophils at low concentration, resulting in a strong chemotactic response. 
The peptide fragments C3a and C5a, released by complement activation, as 
well as formylated peptides secreted from growing  bacterila cells, are 
recognized at high affinity by specific transmembrane G-protein-coupled 
receptors on the neutrophil surface 45.  These are stimulated and activate 
intracellular signaling cascades, resulting in migration of neutrophils from the 
blood to the site of inflammation.  
About 60% of S. aureus strains secrete the chemotaxis inhibitory protein of 
staphylococci CHIPS that can bind avidly to both the formyl peptide receptor 
(FPR) and C5a receptor (C5aR) to block the cognate agonist from binding 46. 
Recent studies identified a FPR- binding domain in the N terminus of CHIPS, 
and showed the Phe residues at position 1 and 3 are critical for activity.  
Once of many ligands recognized by the extracellular adherence protein Eap is 
intracellular adhesion molecule-1 (ICAM-1) on the surface of endothelial cells 47. 
Binding of Eap to ICAM-1 blocks binding of the lymphocyte-function-associated 
antigen LFA-1 on the surface of neutrophils and prevents leucocyte adhesion, 
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diapadesis and extravasation. The Eap protein will likely act in concert to CHIPS 
to inhibit neutrophil recruitment to the site of infection 48.  
 
                 Resistance to phagocytes:  
The primary defense against S. aureus infection is the innate immunity 
mediated by neutrophils. During the phagocytic process, S. aureus bacteria are 
coated with antibodies and complement (serum opsonins) that engage, on 
phagocytic cells, receptor binding the Fc region (tail) of antibodies (Fc receptor) 
and complement receptors (RC1) triggering bacterial uptake. The presence of 
functional antibodies leads to an effective opsonization and recovery from 
infection (Figure 5).  
Figure 4: Inhibition of the neutrophils response to 
infection. a: the chemotaxis inhibitory protein of 
staphylococci (CHIPS) and the extracellular 
adherence protein (Eap) interfere with neutrophil 
chemotaxis and extravasation. b: model for 
interaction between CHIPS and formyl peptide 
receptor (FPR) and C5a receptor. Two distinct but 
closely linked binding domains in CHIPS are 
indicated, one for extreme N terminus of FPR and 
involving residues F1 and F3, the second for a 
domain located between residues 10-20 of the c5a 
form. (Foster T.J.,2005) 
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The ability of S. aureus to avoid opsonins present in the normal serum is an 
important factor in the success of infection. S. aureus expressed surface-
associated anti-opsonic proteins and a polysaccharide capsule that can both 
interfere with the deposition of antibodies and complement formation by 
classical and alternative pathway, or with their access to neutrophils 
complement receptor and Fc receptor. Therefore, efficient phagocytosis by 
neutrophils that requires recognition of bound complement and antibodies is 
compromised. Figure 6 illustrates the highly diverse strategies of 
staphylococcal complement inhibitors. 
Figure 5: Schematic overview of 
opsonophagocytic process: the 
first step is the recognition 
between bacterial antigens and 
antibodies. Subsequently the 
addition of complement leads to 
the binding receptors on 
phagocytic cell, triggering 
bacterial uptake. 
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Protein A is well known for its capacity to bind the Fc part of IgG. Protein A 
amino acid sequence revealed a molecule comprised of five nearly identical Ig-
G binding domains as well as the molecular elements involved in binding Ig 49-51. 
The consequence of interaction between protein A and IgG is to coat the 
surface of the cell with IgG molecules that are in the incorrect orientation to be 
recognized by the neutrophils Fc receptor52.  Mutations in the protein A gene 
(spa) cause significant defects in the pathogenesis of S. aureus infections.  
 
Figure 6: Schematic overview of 
staphylococcal complement 
inhibitor.  S. aureus produces 
several proteins involved that act as 
inhibitors at different steps of 
complement pathway. 
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Staphylokinase  (Sak)  is a potent activator of plasminogen (PLG), the precursor 
of the fibrinolytic protein plasmin. Surface-bound plasmin (PL) has the ability to 
cleave both IgG and C3b. the conversion of PLG by SAK at physiological 
concentrations, leads to the removal of important opsonic molecules necessary 
for recognition by immune cells 53 . PL cleaves human IgG, as well as human 
C3b and C3bi, from the bacterial cell wall leading to impaired phagocytosis by 
human neutrophils. PL cleaves IgG at position Lys 222 and thus removes the 
entire Fc fragment, including the glycosylation site (Asn 297) that is necessary 
for recognition by C1q, thereby inhibiting the activation of the classical 
pathway of complement. In addition, PL-activity created by PLG and SAK led to 
a decrease of the C3b and C3bi molecules at the staphylococcal surface. 
PLG+rSAK cleaved C3b in both the α-chain as well as the β-chain. The decrease 
of C3b molecules will indirectly diminish C3 convertases as well as C5 
convertases. 
 
Staphylococcal complement inhibitor (SCIN) is the most efficient complement 
inhibitor 54. SCIN is a 10 kDa, excreted protein that blocks all complement 
pathways: the lectin, classical and alternative pathway. SCIN efficiently 
prevents phagocytosis and killing of staphylococci and C5a production. SCIN 
acts specifically on surface-bound C3 convertases, stabilizing both C3bBb as 
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well as C4b2a at the surface of the bacterium and at, the same time, 
preventing generation of additional convertases.  
 
The staphylococcal superantigen-like proteins (SSLs) are close relatives of the 
superantigens but are located on a separate gene cluster within a 19-kb region 
of the pathogenicity island SaPIn2. Staphylococcal superantigen-like 7 (SSL-7, 
23.2 kDa) binds human IgA1 and IgA2 resulting in an impaired IgA binding to 
cell surface FcαRI (CD89).  
Extracellular fibrinogen binding molecule (Efb) is a 15.6 kDa excreted molecule 
that was described earlier to bind fibrinogen. Efb blocks classical pathway 
dependent opsonization and subsequent phagocytosis. However, for inhibition 
of the classical and alternative pathway and phagocytosis, high (microgram) 
concentrations of Efb were required. Although the present data on Efb do not 
demonstrate Efb binding to bacterium-bound C3d, a role for Efb in the 
modulation of C3d-mediated recognition by CR2 on B-cells cannot be excluded. 
The C3b-binding site of Efb is distinct from its fibrinogen binding site, in fact, 
Efb can bind both molecules simultaneously 55, 56 . 
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1.8 Staphylococcus aureus- Eukaryotic Interactions 
 
Professional phagocytes like neutrophils and macrophages are designed to 
actively engulf microbes and kill them. Only a few type of microbial pathogen 
can survive phagocytosis by neutrophils and macrophages and they do so by a 
several distinct mechanism to avoid destruction in phagolysosomes 57, 58. 
Surprisingly, S. aureus also appears to be resistant to bactericidal attack inside 
the phagocytic vacuoles of neutrophils which can contain viable intracellular 
bacteria. 59.  During the first step on invasion process S. aureus bacterial cells 
adhere to the cell membrane by means of several surface proteins, including a 
group of surface adhesins called microbial surface components recognizing 
adhesive matrix molecules (MSCRAMMs). Among these MSCRAMMs, the 
fibronecting binding proteins (FnBPs) are necessary and sufficient for 
internalization of bacteria 60, 61. Internalization is an active process with respect 
to the host cell and a passive process with respect to the bacteria 62. 
Internalized S. aureus bacteria reside in the endosomal vacuoles or are divided 
from the endosomal pathway to autophagosomes depending on the cell type 
invaded and/or the S. aureus strains 63. Subsequently, S. aureus escapes into 
the cytoplasm where it eventually kills the host cell through the induction of 
apoptosis 64, 65.  
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Figure 7: schematic overview of internalization process. The internalization can be mediated 
both  by phagocytosis and receptor mediated endocytosis. Basically the entire process can be 
divided in three steps: early endosome, late endosome and lysosome formation respectively.  
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1.9 Intracellular survival of Staphylococcus aureus  
S. aureus was considered for many years to be an extracellular pathogen: the 
fact that S. aureus infections frequently recur, coupled with the observation 
that this pathogen can survive within eukaryotic cells and led to speculation 
that S. aureus may be an intracellular pathogen [66]. Several studies show that 
S. aureus is internalized and survives in a variety on mammalian cells [64, 67-
69].   In order to survive within the host cell, S. aureus must first escape from 
the encapsulating endosomal membrane and then multiply or at least survive 
in the host cell cytoplasm [70, 71]. Several observations suggest the hypothesis 
that the agr locus controls the expression of some of the genes necessary for 
escape from the endosome and further growth in the cytoplasm. After 
escaping the endosome some strains are able to survive within eukaryotic 
cytoplasm for long periods of time and therefore are potentially capable of 
causing persistence or recurrent infections. 
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2. MATERIALS AND METHODS 
2.1 Bacterial strain and culture condition 
S. aureus Newman strain was cultured in tryptic soy broth (TSB composition: 
casein peptone, 17 g/L, dipotassium hydrogen phosphate, 2.5 g/L, glucose, 2.5 
g/L, sodium chloride, 5 g/L, soya peptone , 3 g/L) and 2% NaCl at 37°C. Bacteria 
were grown over night in 20 ml cultures volumes contained in 250 ml 
Erlenmeyer flasks, in a rotary shaker. Bacteria were collected by 10 minutes 
centrifugation at 4000 rpm. 
 
2.2 Animal model  
CD1 out bred female mice (5 weeks old) from Charles River Italia were used to 
test the active immunization. The mice were immunized by intraperitoneal 
injection at days 0, 14 with 10 µg of recombinant proteins formulation in 0.20 
ml in physiological solution in Alum adjuvant. A control group of mice were 
immunized with physiological solution and adjuvant alone. Nine days after the 
last immunization all groups were bled and the blood samples were collected 
to be used in serological analysis. 
 
47 
 
2.3 Cell cultures  
The HL-60 cell line was derived from peripheral blood leukocytes of a 36-yesr-
old Caucasian female with acute promyelocytic leukemia. The wild type cell line 
(ATCC CCL-240) is available from ATCC, whose stock was obtained at passage 7. 
The main characteristic of this cell line is its multi-potentially to differentiate 
into various cell lineages. Environmental condition such as pH and multiple 
chemical inducers can greatly facilitate the differentiation of HL-60 cell lines 
into various myeloid lineages. Treatment with N, N-dimethylformamide (DMF) 
or other polar compounds induce granulocytic differentiation yielding 
polymorphonuclear-like cells (44% myelocytes and 53% PMNs). 
 
2.4 Opsonophagocytosis Killing Assay  
The opsonophagocytosis killing assay (OPKA) is set up in a total reaction 
volume of 125 µl and consists of 4 basic components in the reaction mixture. 
The contents of this reaction typically consist of: 
1. Differentiated HL60 cells 
2. Bacteria 
3. Complement 
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4. Antibody source 
Harvesting Differentiated HL60 cells 
Differentiated HL-60 cells were centrifuged at 1100 rpm for 10 minutes at room 
temperature. The supernatant was removed completely and the cell pellet was 
washed by adding 20 ml of DPBS (Ca++ and Mg++). 
Before the last centrifugation, 50 µl of cell suspension were diluted 1/20 (950 
µl) with DPBS Ca++ and Mg++ to be counted by hemocytometer, count cells 
using the following formula: 
• #cells/ml= #cells counted x dilution factor x 104 
• Total# of cells= # cells counted x dilution factor x 104 X20 
After the counting, the cells were centrifuged at 1100 rpm for 10 minutes at RT 
and the cele pellet was re-suspended in HBSS (without Ca++ and Mg++).  
Bacteria     
S. aureus Newman wt strain was grown in TSB medium for 16-18 hours, and 
then was diluted in HBSS (with Ca++ and Mg++) in order to obtain a final 
concentration of 75 000 CFU/well.    
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Serum        
All sera used in the assay (test or control sera) must be inactivated at 56°C for 
30 minutes to remove the complement function, then mouse antisera was 
prediluted 1:50 in HBSS buffer (with Ca2+/Mg2+) and preincubated with 
bacteria for 20 minutes at 4°C. 
Complement 
 Rabbit complement provided by Calbiochem is kept at -20°C and drag up just 
few seconds before the use.  
A set of negative controls is included in each experiment. They consisted of a 
sample without serum, one containing pre-immune serum, one without 
phagocytic cells and one with heat inactivated complement at 56°C for 30 min. 
The plate, with the reaction mixture, was incubated at 37°C for 1h shaking at 
600 rpm. After the addition of last components of reaction and after the 
incubation of 1h at 37°C, each sample was plated (at the appropriate dilution) 
on TSA agar plates. 
The plates were incubated overnight at 37°C into CO2 incubator and the day 
after the colonies were counted. The killing percentage was calculated respect 
to the sample without serum.  
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2.5 Invasion assay 
A suspension of Newman S. aureus strain in PBS was added to HL-60 cells, 
cultured in RPMI and 10% heat inactivated human serum in 24-wells at 
multiplicity of infection 15:1 (the ratio bacteria: MOI=15:1). HL-60 cells and 
Staphylococcus aureus were co-cultured for 2h in a humidified atmosphere 
containing 5% CO2. Invasion was stopped by putting the plates on ice and 
washing the HL-60 twice with ice-cold PBS to remove non phagocyted bacteria. 
Any remaining extracellular bacteria were killed by gentamycin treatment (50 
µg -1). Then the medium was changed again to fresh media without antibiotic. 
At consecutive hours post-phagocytosis medium was aspired and HL-60 cells 
were lysed. Both conditioned medium and cell lysates were plated onto TSA for 
CFU enumeration.  
 
2.6 Bacterial labeling with PHrodo™ 
Bacteria were grown over night in TSB, washed twice with Phosphate Buffered 
Saline (PBS, pH 7.2–7.4,Gibco) and suspended in half volume of PBS-0.1% 
paraformaldehyde (PFA, Sigma). Cells were incubated at 37 °C for 30 min and 
kept at 2–8 °C in PBS-0.08%PFA. Immediately before labeling, cells were 
washed with PBS, suspended at 20 mg (wet weight)/ml using a freshly 
prepared 100 mM Sodium Hydrogen Carbonate solution pH 8.5 (Merck) and 
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split into aliquots of 750 μl. A 10 mM stock solution of PHrodo™ Succinimidyl 
Ester (Invitrogen) in dimethyl sulfoxide (Sigma) was diluted in the bacterial 
suspension at a final concentration of 0.1 mM. Each sample was incubated for 
45 min at room temperature in the dark and then added with 750 μl of Hank's 
Balanced Salt Solution with Ca2 + and Mg2 + (HBSS, Gibco), then spin down 
with a bench top centrifuge for 60 s at 14,000 ×g. The supernatant was 
aspirated and the pellet suspended in HBSS and stored in the dark at 4 °C for 
two months. Bacterial labeling was evaluated by FACS. The maximal 
fluorescence emission of pHrodo™ labeled GBS was 585 nm. The absolute 
concentration of labeled bacteria was determined by using TruCOUNT tubes 
(BD pharmingen). The beads contained in each tube were suspended in 100 μl 
of PBS and added to 100 μl of bacteria diluted 1/100 in PBS. The absolute cell 
count (N) was calculated using the following equation: N = (number of events 
in region containing bacteria) (number of beads per test ) / (no. of events in 
absolute count beads region), where the number of beads per test was 
provided by BD Pharmingen together with TruCOUNT Absolute Count Tubes. 
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                          2.7 Fluorescence staining and confocal microscopy  
Bacteria were grown in TSB at overnight condition, washed twice with 
Phosphate Buffered Saline (PBS, pH 7.2–7.4,Gibco) and suspended in half 
volume of PBS-0.08% paraformaldehyde (PFA, Sigma).  Bacterial cells were 
incubated at 37 °C for 30min and kept at 2–8 °C in PBS-0.08%PFA. Immediately 
before labeling, cells were washed with PBS, suspended at 20mg (wet 
weight)/ml using a freshly prepared 100mMSodium Hydrogen Carbonate 
solution pH 8.5 (Merck) and split into aliquots of 750 μl. A 10 mM stock 
solution of PHrodo™ Succinimidyl Ester (Invitrogen) in dimethyl sulfoxide 
(Sigma) was diluted in the bacterial suspension at a final concentration of 0.1 
mM. Each sample was incubated for 45 min at room temperature in the dark 
and then added with 750 μl of Hank's Balanced Salt Solution with Ca2+ and 
Mg2+ (HBSS, Gibco), then spin down with a bench top centrifuge for 60 s at 
14,000×g. The supernatant was aspirated and the pellet suspended in HBSS and 
stored in the dark at 4 °C for two months. After differentiation HL-60 cells were 
incubated for 10 minutes at 37°C with wheat germ agglutinin (WGA, 50 µg/ml 
Invitrogen), washed two times in PBS and resuspended in PBS. Differentiated 
HL-60 cells were dispensed in 6 microtiter plates and incubated with labeled 
bacteria for 2 hours in the presence of serum, under the same conditions and 
using the same concentration described for the invasion assay. After incubation, 
cells were washed twice with PBS (centrifuging the plate at 900 rpm for 5 min 
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at 2–8 °C) and fixed with 4% PFA in PBS for 5 min at 2–8 °C. After washing, 
bacteria and cells complex was mounted on a glass slide. Images were acquired 
on a Zeiss LSM 710 laser scanning confocal microscope. 
 
2.8 Scanning electron microscopy 
Infected or non-infected cells were cultured on 6-wells plates in the presence 
of bacteria (MOI:15:1) at different time points. After the treatment, a drop of 
liquid cell suspension was placed on poly-l-lysine treated glass coverslip for five 
minutes. Then, the coverslip was fixed for immersion in a 2,5% glutaraldehyde 
solution in phospate buffer 0,1 M pH 7,2 (PB) for 2 hours at 4°C, washed in PB, 
postfixed in 1% OsO4 in PB for 30 min. at 4°C, dehydrated in ascending alcohol 
series, incubated for three time in tert-butanol and finally freeze dried. 
Afterwards the coverslip was mounted on aluminum stub, coated with 20nm 
gold in Balzers MED010 spattering device and observed in Philps XL20 scanning 
electron microscope at 20kV. 
 
2.9 Transmission electron microscopy  
Infected or non-infected cells were cultured on 6-wells plates in the presence 
of bacteria (MOI:15:1) at different time points. After the incubation, 
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cells/bacteria complex was fixed with Karnovsky solution (2% 
paraformaldehyde, 2.5% glutaraldehyde in 0.2 M sodium cacodylate buffer, pH 
7.4, 30 min at room temperature) washed in the same buffer lacking the 
fixative and post-fixed in 2% osmium tetraoxide for 1h. The pellets were 
dehydrated through serial incubation in graded series of ethanol solutions (30%, 
60%, 90%, and 100%) and finally embedded in Epon. 60 nm sections, obtained 
at Reichert Ultracut E ultramicrotome, were counter-stained with uranyl 
acetate, lead citrate and examined with a Phlips Tecnai g2 spirit electron 
microscope.  
 
2.10 Tomography electron microscopy 
Tomography was performed with a transmission electron microscope CM200 
field emission gun (Philips) operating at 200 kv, equipped with a 2,000 x 2,000 
charge-coupled device camera TVIPS TemCam-F224HD and with  the EMmenu4 
and EM-Tools software packages (both from Tietz Video and Image Processing 
Systems Gmbh). Stained 120-nm-thick sections were decorated on both faces 
with 10 nm colloidal gold particles before observation in the Philips 
transmission electron microscope. Gold particles were used as fiducial position 
markers for image alignment in the tomogram reconstruction procedure. For 
tomographic reconstruction, low-dose tilt series of images were recorded in 
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double tilt axis geometry, at 27,500x magnification (nominal pixel size 0.66 nm), 
with a maximum tilt range of about +60° -60° and tilt steps of 1°. Images were 
recorded with 1 μm of defocus. 
 
2.11 Image analysis  
3D reconstruction was performed using R-weighted back-projection with IMOD 
software (Kremer et al., 1996; Mastronarde, 1997). We exported the 2D 
coordinates of the fiducial markers acquired with IMOD and pasted the two 
series of reference points together with simultaneous alignment. The 
reconstruction was then performed using a weighted back-projection algorithm 
for general geometry (Radermacher, 1992) and local refinement for distortions. 
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             3. RESULTS  
3.1 OPKA on Newman wt strain shows a killing percentage around 
50 %  
Opsonophagocytosis is the primary mechanism for clearance of pathogen from 
the host, and the measurement of opsonophagocytic antibodies appears to 
correlate with vaccine-induced protection. Opsonophagocytic assays are more 
attractive than other measures of in vitro protective immunity because they 
more closely resemble the mechanism of natural immunity, do not require the 
use of animal models, and appear to provide a closer correlation with serotype-
specific vaccine efficacy than ELISAs. In order to assess if mouse sera 
immunized with the final vaccine formulation can elicit antibodies, we 
performed an opsonophagocytosis assay using HL-60 as effector cells.  We 
randomly check the differentiation of cell line from primary cells into 
phagocytes by using flow cytometry analysis (FACS) that allow to test specific 
markers of HL-60. Live HL-60 cells were first gated based on LIVE/DEAD (figure 
1) and then based on forward scatter versus side scatter cytogram. The 
percentage of live cells shown in figure 1 was 80% of total cells and this 
number varied from 72 to 85% in different experiments performed at different 
days [1]. Doublets were eliminated using SSC-W versus SSC-A plot in order to 
keep only singlets. Moreover HL-60 positive to CD-35 and CD11b receptors 
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were gated to identify the neutrophil effector cell population, which 
correspond in figure 1 to 80% of total live cells.  
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Figure 1: Gating strategy to check HL-60 differentiation into neutrophils by 
FACS analysis: discrimination between lived (gated region) and dead HL-60 cells. 
(B) Selection of HL-60 cells using forward scatter (FSC) and side scatter (SSC). (C) 
Discrimination of aggregates from singlets using side scatter–C versus side 
scatter (SSC-W). (D) Neutrophil identification with specific markers of HL-60 
cells differentiation (anti CD-35 and anti CD-11b).  
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To further test if mouse sera immunized with the final vaccine formulation 
could elicit antibodies, we measured functional antibody activity against 
Newman strain in pre- and post-vaccination serum samples. Measurement of 
functional antibody activity was demonstrated by decreased number of 
colonies after 1 hours of incubation. Furthermore the opsonophagocytosis 
process was dependent upon the amount of functional antibody present in 
each sample. We tested four negative controls with all opsonophagocytosis 
components except neutrophils and complement. In addition mouse sera 
immunized only with alum formulation and pre-immune sera were tested. 
Moreover a mouse serum immunized with the final vaccine formulation was 
examined at three different dilutions starting from 1:20 to 1: 500. The 
differences in the percent uptake between pre- and a post-vaccination serum 
sample were shown in the figure 2. We observed that the obtained percentage 
of killing is around 50 % but did not decrease depending on the amount of 
functional antibody. 
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FIGURE 2: Opsonphagocytosis killing assay might be used as a correlate of protection for 
the assessment of functional activity in vitro of protein-induced antibodies in the presence 
of phagocytes and complement. The method was set up with Newman wt strain, HL-60 as 
effector cell, a rabbit complement source and mice antibodies sera immunized against 
combo formulation.  The anti-combo mouse sera were tested at three different dilutions 
starting from 1:20 to 1:500, 5 fold dilution. The mix was incubated for 1 hour and was 
plated on TSA to measure bacterial survival as number of colonies (CFU). The red bars 
show the negative controls with all OPKA components except cells and rabbit complement 
respectively. Additionally a preimmune and a placebo sera were tested. The percent of 
killing was calculated respect to the sample without antibodies after 1h of incubation.  
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In the previous opsonophagocytosis experiment we observed that the 
phagocytic activity of neutrophils was activated already after 1 hour of 
incubation: by this time in fact a percentage of killing around 50% was detected. 
Than in order to verify if the cells maintained their phagocytic ability we 
performed opsonophagocytosis killing assay at different time points from 1 
hour up to 6 hours. In this experiment we used the same condition applied for 
the previous one: infected HL-60 neutrophils were lysed at the indicated 
specific time intervals post phagocytosis and plated onto TSA plates. As 
expected the opsono assay showed that the majority of bacteria were 
internalized already at 1 hour and that the same trend was present at 2 hours 
of incubation. Unexpectedly an increase of bacterial growth occurred starting 
at 3 hours, with similar high number of S. aureus bacteria in both the sample 
without complement (negative control, grey bar) and in the post-vaccination 
serum sample (green bar) (figure 3).  
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Figure 3: OPKA was performed on Newman wt strain at six different time 
points. The assay was performed as described in the Material and Methods 
section. A positive (mouse sera immunized against final Novartis combination) 
and a negative control (sample without rabbit complement) were tested.  We 
reported the number of colonies (CFU)/ml for each time intervals and as mean 
of two analytical section. The orange bar shows the starting number of bacteria 
before the incubation with the neutrophils cells, rabbit complement and 
antibodies.  Starting form 3 hours of incubation S. aureus cells seem to 
duplicate in both negative and positive sample: the same trend was observed 
after 4, 5 and 6 hours of incubation. 
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3.2 Confocal microscopy analysis shows that S. aureus cell are 
engulfed by neutrophils after 1 hour of incubation  
In order to investigate the type of interaction and internalization of S. aureus 
bacteria into the neutrophils we decided to perform a confocal microscopy 
analysis that could allow us to compare the opsono results with a 
morphological observation. Preparatory FACS analysis were set up to select the 
best condition of  dye conjugation: differentiated HL-60 cells were incubated 
with pHrodo™ labeled bacteria in the presence of mouse sera immunized with 
the final vaccine formulation and complement for 1 hour at 37 °C. The 
pHrodo™ label is a pH-sensitive dye and attends as specific sensor of 
phagocytosis and endocytosis. In order to optimize the best conjugation 
between pHrodo™ and S. aureus cells, we tested different concentrations of 
pHrodo™ label and we analyzed them by FACS analysis. At the end of our 
analysis (figure 4), we choose the final concentration of 0.1 mM since the pick 
corresponding to this concentration (blue pick) resulted to be the most shifted 
one from the control pick(red pick).   
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Figure 4: FACS analysis was performed in order to check the best conjugation 
between pHrodo™ label and S. aureus cells. A 10 mM stock solution of 
pHrodo™ was diluted in the bacterial suspension at different concentration, 
from 0.9 mM to 0.1 mM. At the end of the analysis we identified pHrodo™0.1 
mM as the best condition.   
 
Once the dye condition was found we proceed with the confocal microscopy 
analysis: differentiated HL-60 cells were incubated for 1 hour at 37°C in the 
presence of rabbit complement with S. aureus  Newman strain pHrodo™ 
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labeled bacteria. The plasma membrane of neutrophils was stained with wheat 
germ agglutinin (WGA): our observation indicated clearly that neutrophils 
(labeled in blue) maintain their shape, showing a round shape with a diameter 
around 5 µ and that S. aureus  bacteria labeled with pHrodo™ are visible as a 
single yellow dot. Z stacks images of the sample were taken by confocal 
microscopy. Neutrophil plasma membrane (blue) and pHrodo™ labeled 
bacteria (yellow) are shown respectively in panel 1 and 2 of figure 5. The blue 
and the yellow images merged together (panel 3) clearly show that the 
internalized bacteria were brightly fluorescent after engulfment within 
neutrophils.  The panel 5 shows the bright field of HL-60 cells whereas the 
panel 4 and 6 respectively show HL-60 dyed with WGA and phalloidin mixed 
with WGA before bacteria incubation. 
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Figure 5: confocal microscopy analysis shows that S. aureus  cell are engulfed 
by neutrophils after 1 hour of incubation:  differentiated HL-60 cells were 
incubated for 1 hour at 37°C in the presence of rabbit complement with S. 
aureus  Newman strain pHrodo™ labeled bacteria. After washing, cells were 
fixed with 4% paraformaldehyde and plasma membrane of neutrophils was 
stained with wheat germ agglutinin (WGA). Panel 1 and panel 2 show 
respectively the plasma membrane of neutrophils in blue and internalized 
bacteria in yellow.  The merged image (panel 3) clearly shows that the 
internalized bacteria were brightly fluorescent after engulfment within 
neutrophils. The panel 5 shows the bright field of HL-60 cells whereas the panel 
4 and 6 respectively show HL-60 dyed with WGA and phalloidin mixed with 
WGA before bacteria incubation. 
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3.3 S. aureus persists inside neutrophils until the cells lyse  
To determine the intracellular survival/killing rate of S. aureus cells we 
performed an invasion assay at different time points. Cultured HL-60 cells 
engulfed S. aureus strain Newman with the vast of bacteria being internalized 
by 1 hour. The infected HL-60 neutrophils were lysed at specific time intervals 
post-phagocytosis and plates on TSA plates. Based on literature data (ref) we 
selected a multiplicity of infection (MOI) of 15:1; the applied experimental 
condition, in term of ratio between bacteria and cells, was opposite to the 
condition optimized for the opsonophagocytosis killing assay (HL60:CFU=50:1): 
in fact while the aim of opsonophagocytosis killing assay is to assess the 
functional activity of antibodies, the aim of invasion assay is to quantify the 
ability of pathogenic bacteria to invade eukaryotic cells. At MOI 15:1 
neutrophils could not completely eradicate the bacteria, since a burst of 
bacteria growth occurred after 5 hours of incubations. An explosion of live S. 
aureus in the conditioned media may indicate that the bacteria either 
proliferated intracellularly, with large number of bacterial cells being released 
into the media after nuetrophils lysis, or that a small number of surviving 
intracellular bacteria escaped and multiplied vigorously in the media, killing the 
HL-60 cells in the process.  
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3.4 Ultrastructural microscopy analysis shows that survival of 
bacteria in neutrophils affect the viability of host cells  
To determine whether bacteria engulfment affects the viability of host cells, we 
performed a negative staining analysis on HL-60 cells at different time points, 
starting from 1 hour to 6 hours. Negative staining is a sample preparation 
method in which biological samples are embedded in a thin layer of dried 
 
Figure 6: Invasion assay show that S. aureus persist intracellularly presenting a burst 
of growth after 5 hours. CFU of S. aureus were counted both in cell lysates and 
culture medium over six consecutive hours. Neutrophils were allowed to engulf S. 
aureus at MOI of 15:1 for 2 h and extracellular bacteria killed by gentamycin. 
Neutrophils were cultured in media without antibiotics. At consecutive hours post-
phagocytosis medium was aspired and HL-60 were lysed. Both conditioned medium 
and cell lysates were plated onto TSA for CFU enumeration. 
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heavy metal salt to increase specimen contrast. For this reason negative 
staining electron microscopy allows a rapid examination of macromolecular 
complexes and offers us the possibility to obtain morphological and structural 
information of the whole bacterial cells and even of their superficial 
components as the cells membrane. Negative stained samples were than 
analyzed with a Transmission Electron Microscope (TEM) operating at 120kV. 
We firstly co-incubated bacteria and neutrophils in the presence of 
complement and mouse serum after 1, 3 and 5 hours of incubation respectively 
(figure 7) and after intense washing, we spotted 5 microliters of the samples on 
carbon coated grids. Negative stained samples were than observed at the TEM 
and images collected. After 1 hour (panel A) the cell membrane appears 
completely intact and undamaged even when observed at higher resolution 
(panel B).  Starting from 3 hours of incubation (panel C), we observed many 
bacteria that invaded neutrophils causing a strong change in the cell 
membrane morphology that now appear totally disintegrated.  By 5 hours the 
number of bacteria invading cells is considerably increased and the cell is 
completely dissolved.  
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Figure 7: Negative staining electron microscopy of HL-60 cells incubated with S. 
aureus bacteria.  Bacteria and neutrophils were co-incubated in the presence 
of complement and mouse serum after 1, 3 and 5 hours respectively. After 1 
hour (panel A) the cell membrane appears completely intact and undamaged 
even if it is observed at higher resolution (panel B).  At 3 hours of incubation 
(panel C), bacteria invade neutrophils causing a strong change in the cell 
membrane morphology that is totally disintegrated.  By 5 hours (panel D) the 
number of bacteria invading cells is increased and the cell is dissolved. 
 
As a further step of our morphological analysis of the infected cells we decided 
to perform a scanning electron microscopy analysis (SEM) that gives high-
resolution images and provides morphological and compositional information. 
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We used the same experimental condition described before for the negative 
staining analysis: we collected scanning electron microscopy images at 
different time points until 8 hours of incubation. In two independent 
experiments we found that engulfment of S. aureus clearly damage cell 
membrane by 4 hours of incubation (figure 8). Before the incubation (panel A) 
HL-60 cells are perfectly sticking on scanning microscopy slide, showing 
numerous protrusion/extension over the surface. Starting from 2 hours, there 
is a decrease of protrusion that suggests a decrease of adhesiveness (panel B). 
By 4 hours, we can appreciate a structural surface changes as well as loss of 
structural components. By 6 hours, as confirmed also by 8 hours, many blebs 
are present on HL-60 cell surface, demonstrating definitely the evolution of 
changes in cell membrane morphology. Collectively these data, together with 
invasion assay, argue that S. aureus persists inside HL-60 neutrophils in 
continuously decreasing number until the exhausted cells allow bacteria to 
escape into the conditioned medium, where they proliferate. 
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Figure 8: Scanning electron microscopy analysis (SEM) shows that survival of 
bacteria in neutrophils affect the viability of host cells. We collected scanning 
electron microscopy images at different time points until 8 hours of incubation. 
We found that engulfment of S. aureus clearly damage cell membrane by 4 
hours of incubation. Before the incubation (panel A) HL-60 cells are perfectly 
sticking on scanning microscopy slide, showing numerous protrusion/extension 
over the surface. Starting from 2 hours, there is a decrease of protrusion that 
suggests a decrease of adhesiveness (panel B). By 4 hours, we can appreciate a 
structural surface changes as well as loss of structural components. By 6 hours, 
as confirmed also by 8 hours, many blebs are present on HL-60 cell surface, 
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demonstrating definitely the evolution of changes in cell membrane 
morphology. 
 
3.5 S. aureus perseveres in intracellular vacuoles of Hl-60 cells 
The strategies employed by obligate intracellular pathogen to avoid 
intracellular killing by professional phagocytes can be broadly categorized 
either as immediate escape from the phagosome into the cytoplasm either as 
modification of the phagosome preventing the fusion with lysosoms. Applying 
either scanning electron microscopy either negative staining techniques we 
appreciate the overall changes on HL-60 cells surface but we cannot obtain 
information on structural transformations within neutrophils. Furthermore in 
order to investigate specific localization of S. aureus we analyzed sections of 
HL-60 cells incubated with S. aureus for 2 hours, by transmission electron 
microscopy (TEM). We used epoxin resin to embed the specimens and we cut 
thin slices of material by an ultramicrotome. An overall image of the sectioned 
cell is shown in the Figure 9:  the neutrophil HL-60 cells (panel A) have a 
nucleus that is segmented into two lobes and presents several mature granules; 
after the incubation with S. aureus bacteria HL-60 cells (panel B) assume an 
apoptotic morphology, including nuclear condensation and fragmentation as 
well as cytoplasmic vacuolization. 
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Figure 9: Transmission electron microscopy (TEM) micrographs show an overall 
picture of the whole HL-60 cells incubated with S. aureus for 2 hours. 
Neutrophil HL-60 cells (panel A) have a nucleus that is segmented into two 
lobes and presents several mature granules; after the incubation with S. aureus 
bacteria HL-60 cells (panel B) assume an apoptotic morphology, including 
nuclear condensation and fragmentation as well as cytoplasmic vacuolization. 
 
In order to investigate the specific pathway adopted by S. aureus bacteria we 
performed a second transmission electron microscope analysis, using the same 
condition described in the previous experiment. Through transmission electron 
analysis (figure 9) we shown that phagocytosis following a sequence of events: 
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(a) recognition between epitopes on bacterial surface and receptors expressed 
on cell wall, (b) adherence of S. aureus to the HL-60 cell, (c) engulfment of the 
bacteria within a phagosome, and (d) transfer of the complex that appears 
distant to the cell membrane and. As expected, HL-60 cell is unable to kill the 
ingested pathogen: considerable numbers of bacteria were found in vacuoles 
whose membranes were partially or totally degraded. Finally, it is important to 
underline that dividing intact bacteria were frequently observed in vacuoles. 
Collectively these results strongly support our contention that S. aureus can 
survive intracellularly killing inside vescular compartments.  
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Figure 9: Transmission electron micrographs on HL-60 and S. aureus cells were 
performed. Through this technique we demonstrated that phagocytosis event 
follows a sequence of specific events: (a) recognition between epitopes on 
bacterial surface and receptors expressed on cell wall, (b) adherence of S. 
aureus to the HL-60 cell, (c) formation of cup-like processes on the cell surface, 
and (d) elongation of the cup and engulfment of the bacteria within a 
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phagosome. As expected, HL-60 cell is unable to kill the ingested pathogen: 
considerable numbers of bacteria were found in vacuoles whose membranes 
were partially or totally degraded. Finally, it is important to underline that 
dividing intact bacteria were frequently observed in vacuoles. Collectively these 
results strongly support our contention that S. aureus can survive intracellularly 
killing inside vesicular compartments. 
 
3.6 Electron tomography analysis of S. aureus bacteria in 
intracellular vacuoles of Hl-60 cells 
Visualizing the dynamic molecular architecture of cells is instrumental for 
answering fundamental questions in cellular and structural biology. Although 
modern microscopy techniques, including fluorescence and conventional 
electron microscopy, have allowed us to gain insights into the molecular 
organization of cells, they are limited in their ability to visualize 
multicomponent complexes in their native environment. Electron tomography 
(ET) allows cells, and the macromolecular assemblies contained within, to be 
reconstructed in situ, at a resolution of 2–6 nm. Electron tomography is a 
unique technique in structural biology research because it is the only tool that 
enables direct visualization of the cellular space at molecular resolution. In 
other words ET may bridge the resolution gap between cellular and structural 
biology. 
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We collected 5 different tomograms and for each tomogram around 120 
images were kept, one for each tilt angle.  We reported a single whole picture 
(figure 10) corresponding respectively to the bottom (panel 1), center (panel 2) 
and top (panel 3) part of the tomogram. The detailed analysis of thin 
computational sections covering the whole volume for each of the tomograms 
included in this study was used to make important conclusions (Figure 10).  
In electron tomography all useful 3D information is actually extracted from this 
analysis of planes. In addition the volumetric representation of reconstructed 
factories using programs such as Chimera helps us to summarize our findings 
and to highlight some important features of S. aureus cells. The extraordinary 
complexity of volumes generated by ET of highly-preserved cells is apparent in 
these representations. In order to facilitate their interpretation, noise 
reduction and segmentation have been applied to display the most important 
features. In our model the structure reveals the presence of intact bacterial 
membrane within neutrophil vacuoles. The S. aureus membrane appears 
completely undamaged and integral in contrast with the physiological process 
of phagocytosis through vacuoles progression.  Moreover many vacuoles are 
present both inside and outside the vacuoles containing bacterium as usually 
happen during the phagocytosis process (Figure 11). 
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Figure 10: electron tomography on 
S. aureus bacteria trapped within 
HL-60 vacuoles: We reported a 
single whole picture (figure 10) 
corresponding respectively to the 
bottom (panel 1), center (panel 2) 
and top (panel 3) part of the 
tomogram. The S. aureus 
membrane appears completely 
undamaged and integral in 
contrast with the physiological 
process of phagocytosis through 
vacuoles progression.  Moreover 
many vacuoles are present both 
inside and outside the vacuoles 
containing bacterium as usually 
happen during the phagocytosis 
process 
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Figure 11: A model of S. aureus survival within HL-60 neutrophils vacuoles. The S. aureus 
membrane appears completely undamaged and integral in contrast with the 
physiological process of phagosytosis through vacuoles progression.  Moreover many 
vacuoles are present both inside and outside the vacuoles containing bacterium as 
usually happen during the phagocytosis process. 
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5. DISCUSSION 
The principal immune effector mechanism by which humans are protected from 
Gram positive bacteria such as S. aureus is antigen specific antibody and 
complement dependent opsonophagocytosis [1]. This process can be measured in 
vitro using the opsonophagocytic killing assay (OPKA), which is a complex assay 
composed of live S. aureus bacteria, a complement source, phagocytic effector 
cells such as differentiated HL-60 cells, and test serum[2, 3].  
During my PhD, we investigated the impact on the OPKA of S. aureus antigens 
vaccine formulation, measuring functional antibody activity against S. aureus 
Newman strain. We observed that the obtained percentage of killing is around 
50 %, demonstrating that mouse antibodies immunized with S. aureus antigens 
vaccine formulation play a role during the clearance of pathogen (figure 2). 
Furthermore we have proven that the phagocytic activity of neutrophils was 
activated after 1 hour of incubation and that cells maintained this specific 
capability up to 2 hours. Unexpectedly we observed an increase of bacterial 
growth occurred starting from 3 hours, suggesting that HL-60 cells lost their 
phagocytic activity (figure 3)[4, 5]. These data suggest that S. aureus can survive 
inside neutrophils and supports current in vitro studies of S. aureus invasion and 
survival in epithelial cells, endothelial cells, and osteoblasts [6, 7]. This evidence of 
course is a significant problem because neutrophils are the most prominent 
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cellular defense against S. aureus infections and moreover suggest that the 
surviving of S. aureus inside neutrophils contributes to infections [8]. 
Subsequently, to determine the intracellular survival/killing rate of S. aureus cells 
we performed an invasion assay at different time points, demonstrating definitely 
that this bacterium can not only persist for several hours inside neutrophils, but 
ultimately is able to escape the intracellular confinement and proliferate rapidly in 
the conditioned media (figure 6)[9]. Furthermore by examining transmission 
electron microscopy micrographs of infected neutrophils at different time points, 
several important observations were made: after 1 hour of incubation the cell 
membrane appears completely intact and undamaged but starting form 3 hours 
many bacteria invaded neutrophils causing a strong change in cell membrane 
morphology that appear completely disintegrated.  
As a further step of our morphological analysis we demonstrated by scanning 
electron microscopy technique that S. aureus compromises the viability of HL-60 
neutrophils, confirming definitely the evolution of changes in cell membrane 
morphology.  Taken together, these results strengthen the idea that S. aureus has 
evolved numerous mechanisms to evade host defense strategies employed by 
neutrophils, including the ability to modulate normal neutrophil turnover and that 
this critical process should contribute to dissemination of  the pathogen to 
infections site.[10].   
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Finally in order to investigate the specific localization of S. aureus we performed an 
ultrastructural analysis by   transmission electron microscopy: we observed that 
after the incubation with pathogen HL-60 assumed an apoptotic morphology, 
including nuclear condensation and fragmentation as well as cytoplasmic 
vacuolization (figure 9, panel B).  
The development of electron microscopy and its application to biological studies 
allowed the morphology of many organelles to be revealed. Electron-microscopy 
can provide a high resolution view of the overall architecture of cells at high 
resolution of a few nanometers. More recently, the use of electron tomography 
has allowed this information to be extrapolated to three dimensions and to be 
used to build a molecular map of cells in physiologically relevant conditions at 
resolution of a few nanometers [11, 12]. To this purpose we recorded a series of 
two-dimensional (2D) electron micrograph projections at varying angles (tilt series) 
and then merging these projections to produce a 3D reconstruction.  In our final 
model the S. aureus membrane appears completely undamaged and integral in 
contrast with the physiological process of phagosytosis through vacuoles 
progression. S. aureus bacteria show a homogenous distribution of the density in 
all the three dimensions (X, Y, Z). No preferential density distribution has been 
noticed and the cell turgor is maintained. All these evidences definitely explain the 
ability of the pathogen to survive inside the endosomal vacuoles and should be the 
cause of the low killing level.  
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